Article

Proteome-wide association study identifies novel Alzheimer's disease- associated proteins

2024-07-22

Abstract excerpt

<title>Abstract</title> <p>Background Alzheimer's disease (AD) is a progressive neurodegenerative disease, with a critical shortage of effective prevention and treatment options. Here, we aimed to identify proteins whose genetically regulated plasma levels were associated with AD and its related phenotypes. Methods An integrative proteome-wide search using Olink-based plasma proteomes (N = 45,540) from the UK B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1b88511b-464c-522a-a346-185db5bfbb5f
DOI: 10.21203/rs.3.rs-4648743/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsDOI 10.21203/rs.3.rs-4648743/v1Read

Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tearsSemantic proximity Read

Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s diseaseSemantic proximity Read

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later lifeSemantic proximity Read

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s diseaseSemantic proximity Read

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discoverySemantic proximity Read

Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity Read

A genetic and proteomic comparison of key AD biomarkers across tissuesSemantic proximity Read

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Multi-tissue proteomics identifies molecular signatures for sporadic and genetically defined Alzheimer disease casesSemantic proximity Read

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Novel Plasma Proteins Associated With Alzheimer’s Disease Risk in APOE ε4 Carriers and Non-carriersSemantic proximity Read

CSF proteogenomics implicates novel proteins and humoral immunity in Alzheimer’s disease riskSemantic proximity Read